Mesoblast

(NASDAQ) MESO

Current Price$15.71

Market Cap$2.03B

Since IPO (2005)+93%

5 Year+3%

1 Year+32%

1 Month-0%

Mesoblast Financials at a Glance

Market Cap

$2.03B

Revenue (TTM)

$17.20M

Net Income (TTM)

$102.14M

EPS (TTM)

$-0.74

P/E Ratio

-21.34

Dividend

$0.00

Beta (Volatility)

1.36 (Average)

Dividend

$0.00

Beta (Volatility)

1.36 (Average)

Price

$15.71

Volume

147,902

Open

$15.85

Price

$15.71

Volume

147,902

Open

$15.85

Previous Close

$15.74

Daily Range

$15.61 - $15.89

52-Week Range

$9.88 - $21.50

Dividend

$0.00

Beta (Volatility)

1.36 (Average)

Price

$15.71

Volume

147,902

Open

$15.85

Previous Close

$15.74

Daily Range

$15.61 - $15.89

52-Week Range

$9.88 - $21.50

MESO News

Physician going over results with patient

Why Mesoblast Stock Plummeted on Friday

Jon QuastDec 18, 2020

Why Mesoblast Stock Is Tanking Today

Keith SpeightsDec 15, 2020

Scientist in lab looking through microscope

Why Mesoblast Stock Is Blasting Off Today

Keith SpeightsNov 20, 2020

Page 1

MESO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mesoblast

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Silviu Itescu, PhD

Website

www.mesoblast.com

Headquarters

Melbourne, VIC 3000, AU

MESO Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-6%

Net Income Margin

-5%

Return on Equity

-18%

Return on Capital

-14%

Return on Assets

-10%

Earnings Yield

-4.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.03B

Shares Outstanding

129.28M

Volume

147.90K

Avg. Volume

254.51K

Financials (TTM)

Gross Profit

$12.07M

Operating Income

$62.44M

EBITDA

$73.66M

Operating Cash Flow

$49.95M

Capital Expenditure

$730.00K

Free Cash Flow

$50.68M

Cash & ST Invst.

$161.16M

Total Debt

$128.16M

Mesoblast Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$7.02M

+458.6%

Gross Profit

$16.23M

-69.4%

Gross Margin

-2.31%

N/A

Market Cap

$2.03B

N/A

Market Cap/Employee

$27.88M

N/A

Employees

N/A

Net Income

$27.10M

+2.2%

EBITDA

$19.64M

-28.7%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$5.57M

+93.7%

Accounts Receivable

$43.30M

+2465.2%

Inventory

$21.66M

-10.5%

Long Term Debt

$66.02M

-37.8%

Short Term Debt

$69.12M

+247.6%

Return on Assets

-9.99%

N/A

Return on Invested Capital

-13.66%

N/A

Free Cash Flow

$15.69M

-51.2%

Operating Cash Flow

$15.56M

-50.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

OCULOcular Therapeutix, Inc.

OCULOcular Therapeutix, Inc.$9.43+0.64%

GLPGGalapagos N.V.

GLPGGalapagos N.V.$28.00+0.61%

GPCRStructure Therapeutics Inc.

GPCRStructure Therapeutics Inc.$42.21+1.83%

NUVBNuvation Bio Inc.

NUVBNuvation Bio Inc.$4.49+0.90%

QUREuniQure N.V.

QUREuniQure N.V.$19.13-4.11%

VRDNViridian Therapeutics, Inc.

VRDNViridian Therapeutics, Inc.$13.42-0.45%

EWTXEdgewise Therapeutics, Inc.

EWTXEdgewise Therapeutics, Inc.$30.61-1.13%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

SOUNSoundHound AI

SOUNSoundHound AI$9.56+0.20%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

Questions About MESO

What is the current price of Mesoblast?

Mesoblast is trading at $15.74 per share.

What is the 52-week range for Mesoblast?

Over the past 52 weeks, Mesoblast has traded between $9.88 and $21.50.

How much debt does Mesoblast have?

As of the most recent reporting period, Mesoblast reported total debt of $128.16M.

How much cash does Mesoblast have on hand?

Mesoblast reported $161.55M in cash and cash equivalents in its most recent financial results.

What is Mesoblast’s dividend yield?

Mesoblast does not currently have a dividend yield.

Mesoblast

Mesoblast Financials at a Glance

MESO News

Why Shares of Mesoblast Are Down Monday

Why Shares of Mesoblast Are Plunging Friday

Why Mesoblast Limited Stock Is Jumping Today

Why Mesoblast Limited Is Rising Today

Why Mesoblast Stock Skyrocketed Today

Why Mesoblast Stock Plummeted on Friday

Why Mesoblast Stock Is Tanking Today

Why Mesoblast Stock Is Blasting Off Today

MESO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Mesoblast

MESO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Mesoblast Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MESO

What is the current price of Mesoblast?

What is the 52-week range for Mesoblast?

How much debt does Mesoblast have?

How much cash does Mesoblast have on hand?

What is Mesoblast’s dividend yield?

Premium Investing Services